R. Mazeron

3.6k total citations · 1 hit paper
100 papers, 2.0k citations indexed

About

R. Mazeron is a scholar working on Obstetrics and Gynecology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R. Mazeron has authored 100 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Obstetrics and Gynecology, 38 papers in Surgery and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R. Mazeron's work include Endometrial and Cervical Cancer Treatments (52 papers), Ovarian cancer diagnosis and treatment (25 papers) and Management of metastatic bone disease (22 papers). R. Mazeron is often cited by papers focused on Endometrial and Cervical Cancer Treatments (52 papers), Ovarian cancer diagnosis and treatment (25 papers) and Management of metastatic bone disease (22 papers). R. Mazeron collaborates with scholars based in France, Austria and Denmark. R. Mazeron's co-authors include Christine Haie-Méder, Cyrus Chargari, Lars Fokdal, Richard Pötter, Christian Kirisits, Kari Tanderup, Peter Hoskin, Isabelle Dumas, Philippe Morice and Eleonor Rivin del Campo and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

R. Mazeron

96 papers receiving 2.0k citations

Hit Papers

Effect of tumor dose, volume and overall treatment time o... 2016 2026 2019 2022 2016 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer
    2016 244 citations Kari Tanderup, Lars Fokdal et al. Radiotherapy and Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Mazeron France 22 1.4k 1.0k 441 433 385 100 2.0k
Lars Fokdal Denmark 28 1.8k 1.3× 1.4k 1.3× 806 1.8× 517 1.2× 485 1.3× 86 2.8k
B. Castelain France 18 892 0.7× 743 0.7× 190 0.4× 290 0.7× 428 1.1× 62 1.7k
Barbara Šegedin Slovenia 22 937 0.7× 843 0.8× 386 0.9× 422 1.0× 226 0.6× 86 1.7k
A. Gerbaulet France 15 724 0.5× 661 0.6× 176 0.4× 285 0.7× 303 0.8× 53 1.6k
D. Jeffrey Demanes United States 25 811 0.6× 747 0.7× 1.3k 2.9× 1.5k 3.4× 281 0.7× 95 2.9k
Kathryn M. Greven United States 34 1.2k 0.9× 1.3k 1.2× 229 0.5× 804 1.9× 1.2k 3.2× 92 3.6k
Luis Delclos United States 26 823 0.6× 958 0.9× 159 0.4× 435 1.0× 573 1.5× 64 2.0k
A Gerbaulet France 25 575 0.4× 830 0.8× 168 0.4× 381 0.9× 382 1.0× 65 1.7k
D. Chassagne France 23 824 0.6× 1.0k 1.0× 229 0.5× 518 1.2× 323 0.8× 85 2.5k
John T. Comerci United States 20 969 0.7× 637 0.6× 128 0.3× 135 0.3× 711 1.8× 60 1.7k

Countries citing papers authored by R. Mazeron

Since Specialization
Citations

This map shows the geographic impact of R. Mazeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Mazeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Mazeron more than expected).

Fields of papers citing papers by R. Mazeron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Mazeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Mazeron. The network helps show where R. Mazeron may publish in the future.

Co-authorship network of co-authors of R. Mazeron

This figure shows the co-authorship network connecting the top 25 collaborators of R. Mazeron. A scholar is included among the top collaborators of R. Mazeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Mazeron. R. Mazeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turpin, Anthony, Jean‐Marie Michot, Emmanuelle Kempf, et al.. (2017). Le lymphome de Hodgkin : stratégies thérapeutiques actuelles et futures. Bulletin du Cancer. 105(1). 81–98. 3 indexed citations
2.
Annède, Pierre, Thomas Seisen, R. Mazeron, et al.. (2017). Inflammatory bowel diseases activity in patients undergoing pelvic radiation therapy. Journal of Gastrointestinal Oncology. 8(1). 173–179. 14 indexed citations
3.
Barillot, I., et al.. (2016). Patients porteurs d’un stimulateur cardiaque ou d’un défibrillateur implantable. Cancer/Radiothérapie. 20. S256–S258. 5 indexed citations
4.
Chargari, Cyrus, R. Mazeron, Alexandre Escande, et al.. (2016). Image-guided adaptive brachytherapy in cervical cancer: Patterns of relapse by brachytherapy planning parameters. Brachytherapy. 15(4). 456–462. 12 indexed citations
5.
6.
7.
Mazeron, R., I. Barillot, F. Mornex, & P. Giraud. (2016). Radiothérapie et grossesse. Cancer/Radiothérapie. 20. S264–S268. 3 indexed citations
8.
Chargari, Cyrus, R. Mazeron, Ariane Dunant, et al.. (2016). Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy. Clinical & Experimental Metastasis. 33(8). 775–785. 6 indexed citations
9.
Tanderup, Kari, Christian Kirisits, Kathrin Kirchheiner, et al.. (2015). SP-0126: Dose response and dose effect of IGABT in cervix cancer. Radiotherapy and Oncology. 115. S59–S60. 2 indexed citations
10.
Bidault, François, R. Mazeron, Pierre Maroun, et al.. (2015). Clinical Experience with Pulse Dose Rate Brachytherapy for Conservative Treatment of Penile Carcinoma and Comparison with Historical Data of Low Dose Rate Brachytherapy. Clinical Oncology. 27(7). 387–393. 16 indexed citations
11.
Mazeron, R., et al.. (2015). Implementation of the global risk analysis in pulsed-dose rate brachytherapy: Methods and results. Cancer/Radiothérapie. 19(2). 89–97. 1 indexed citations
12.
Mazeron, R., et al.. (2015). Impact de la radiothérapie sur la fertilité féminine. Bulletin du Cancer. 102(5). 470–476. 5 indexed citations
13.
Mazeron, R., et al.. (2013). Brachytherapy for isolated tongue metastasis of renal clear cell carcinoma. European Annals of Otorhinolaryngology Head and Neck Diseases. 130(3). 149–151. 12 indexed citations
14.
Charra-Brunaud, C. & R. Mazeron. (2013). Curiethérapie dans les cancers de l’endomètre. Cancer/Radiothérapie. 17(2). 106–110. 7 indexed citations
15.
Mazeron, R., Agathe Bajard, X. Montbarbon, et al.. (2012). Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence. Radiation Oncology. 7(1). 46–46. 26 indexed citations
16.
Mazeron, R., B. Étienne-Mastroïanni, David Pérol, et al.. (2010). Predictive Factors of Late Radiation Fibrosis: A Prospective Study in Non–Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 77(1). 38–43. 48 indexed citations
17.
Rouge, T. De La Motte, Judith Michels, Caroline Even, et al.. (2009). Nouvelles molécules et thérapeutiques moléculaires ciblées dans les adénocarcinomes ovariens de stades avancés. Bulletin du Cancer. 96(12). 1215–1224. 5 indexed citations
18.
19.
Mazeron, R., Yungan Tao, Antoine Lusinchi, & Jean Bourhis. (2009). Current concepts of management in radiotherapy for head and neck squamous-cell cancer. Oral Oncology. 45(4-5). 402–408. 39 indexed citations
20.
Mornex, F., et al.. (2004). [Chemoradiation for pancreatic adenocarcinoma].. PubMed. 8 Suppl 1. S80–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lars Fokdal Breakdown of academic impact, for papers by B. Castelain Breakdown of academic impact, for papers by Barbara Šegedin Breakdown of academic impact, for papers by A. Gerbaulet Breakdown of academic impact, for papers by D. Jeffrey Demanes Breakdown of academic impact, for papers by Kathryn M. Greven Breakdown of academic impact, for papers by Luis Delclos Breakdown of academic impact, for papers by A Gerbaulet Breakdown of academic impact, for papers by D. Chassagne Breakdown of academic impact, for papers by John T. Comerci
Rankless by CCL
2026